- Home
- RMBI vs TVGN Comparison
RMBI vs TVGN Comparison
Compare RMBI & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBI
- TVGN
- Stock Information
- Founded
- RMBI 1887
- TVGN 2020
- Country
- RMBI United States
- TVGN United States
- Employees
- RMBI N/A
- TVGN N/A
- Industry
- RMBI Major Banks
- TVGN Blank Checks
- Sector
- RMBI Finance
- TVGN Finance
- Exchange
- RMBI Nasdaq
- TVGN Nasdaq
- Market Cap
- RMBI 127.9M
- TVGN 109.7M
- IPO Year
- RMBI 2019
- TVGN N/A
- Fundamental
- Price
- RMBI $12.79
- TVGN $0.45
- Analyst Decision
- RMBI
- TVGN
- Analyst Count
- RMBI 0
- TVGN 0
- Target Price
- RMBI N/A
- TVGN N/A
- AVG Volume (30 Days)
- RMBI 7.6K
- TVGN 167.1K
- Earning Date
- RMBI 10-18-2024
- TVGN 08-14-2024
- Dividend Yield
- RMBI 4.40%
- TVGN N/A
- EPS Growth
- RMBI N/A
- TVGN N/A
- EPS
- RMBI 0.81
- TVGN N/A
- Revenue
- RMBI $41,636,699.00
- TVGN N/A
- Revenue This Year
- RMBI N/A
- TVGN N/A
- Revenue Next Year
- RMBI N/A
- TVGN N/A
- P/E Ratio
- RMBI $15.77
- TVGN N/A
- Revenue Growth
- RMBI N/A
- TVGN N/A
- 52 Week Low
- RMBI $9.44
- TVGN $0.40
- 52 Week High
- RMBI $13.00
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- RMBI 61.17
- TVGN 39.84
- Support Level
- RMBI $11.40
- TVGN $0.42
- Resistance Level
- RMBI $12.80
- TVGN $0.52
- Average True Range (ATR)
- RMBI 0.37
- TVGN 0.06
- MACD
- RMBI 0.00
- TVGN 0.00
- Stochastic Oscillator
- RMBI 95.71
- TVGN 30.97
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.